Insulin Aspart Protamine And Insulin Aspart Injection, Suspension
Product Images NDC 70518-3236

Product Visual Gallery

This gallery contains 48 technical images submitted to the FDA as part of the official labeling for Insulin Aspart Protamine And Insulin Aspart (NDC 70518-3236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Insulin Aspart 70 30 Flexpen 100 Units mL(u 100) 70518 3236 00

Label for Insulin Aspart Protamine 100 Units/mL (U-100) injectable suspension in a prefilled syringe format. The label indicates the product name as Insulin Aspart 70/30 FlexPen with 5 syringes per package. It includes instructions for subcutaneous use and careful shaking before use. The label notes storage advisories and repackaging information by RemedyRepack Inc., with original manufacturing by Novo Nordisk Inc.*

FDA Label Image

Molecular Chain Of Insulin Aspart. (Image 01)

Chemical structure of insulin aspart showing the amino acid sequence and disulfide bonds connecting the A-chain and B-chain peptides. The diagram labels each amino acid residue sequentially in both chains.*

FDA Label Image

Figure 2 (Image 02)

A line graph comparing glucose infusion rates over 24 hours for Insulin Aspart Protamine and Insulin Aspart Mix 70/30 and Novolin 70/30. The x-axis represents time in hours, and the y-axis represents glucose infusion rate in mg/kg/min. The graph shows the pharmacodynamic profiles of these insulin formulations.*

FDA Label Image

Figure 3 (Image 03)

A line graph comparing the mean serum insulin concentration (mU/L) over a 24-hour period for Insulin Aspart Protamine and Insulin Aspart Mix 70/30 versus Novolin 70/30. The x-axis represents time in hours, and the y-axis shows mean serum insulin levels, with error bars depicting the standard error of the mean (SEM).*

FDA Label Image

Vial Figure (Image 04)

An illustration showing a vial with labeled components: tamper resistant cap, rubber stopper, and an indication that these are under the cap.*

FDA Label Image

Needle Components. (Image 05)

Illustration showing the components of three needle types: NovoFine, NovoFine Plus, and NovoTwist. Each type is depicted with its big outer needle cap, inner needle cap, needle, and protective tab arranged in sequence, illustrating their assembly and parts.*

FDA Label Image

Figure D: Screw Needle On. (Image 06)

An instructional diagram illustrating how to attach or prepare injection devices labeled NovoFine and NovoFine Plus, and NovoTwist. The two-panel image uses arrows to demonstrate the twisting or uncapping action required for device assembly or use.*

FDA Label Image

Figure L (Image 07)

An illustration showing the tip of an insulin injection pen with a needle attached, poised above skin, indicating the subcutaneous injection route. The image is likely to represent the administration method for Insulin Aspart Protamine and Insulin Aspart Mix 70/30 injection, 100 units/mL, by REMEDYREPACK INC.*

FDA Label Image

Image Of Possible Injection Sites. (Image 09)

An anatomical diagram showing front and back views of a human torso with highlighted injection sites on the abdomen and upper buttocks. This illustration likely indicates common subcutaneous injection locations.*

FDA Label Image

Important (Image 10)

FDA Label Image

Important (Image 11)

FDA Label Image

Important (Image 12)

FDA Label Image

Important (Image 13)

FDA Label Image

Important (Image 14)

FDA Label Image

Important (Image 15)

FDA Label Image

Important (Image 16)

FDA Label Image

Important (Image 17)

FDA Label Image

Important (Image 18)

FDA Label Image

Important (Image 19)

FDA Label Image

Important (Image 20)

FDA Label Image

Important (Image 21)

FDA Label Image

Important (Image 22)

FDA Label Image

Important (Image 23)

FDA Label Image

Important (Image 24)

FDA Label Image

Figure E: Pull Off Outer Needle Cap. (Image 25)

An instructional illustration showing steps for using a NovoFine or NovoFine Plus needle and a NovoTwist needle. The image highlights how to attach or handle these needles, indicating proper needle connection to the pen device for injection.*

FDA Label Image

Figure F: Pull Off Inner Needle Cap. (Image 26)

Instructional diagram showing how to use NovoFine and NovoTwist needles for injection. The left panel depicts holding a NovoFine needle and the right panel shows holding a NovoTwist needle, each with a hand demonstrating attachment or removal motion. No specific product information is included beyond the needle type names.*

FDA Label Image

Overview Of Flexpen (Image 27)

Illustration diagram of the Insulin Aspart Protamine and Insulin Aspart Mix 70/30 FlexPen injection device. The diagram labels parts including the pen cap, rubber stopper, 12-unit glass ball, cartridge, cartridge scale, pointer, dose selector, and push-button, demonstrating the components of this subcutaneous injectable suspension pen.*

FDA Label Image

Figure J (Image 28)

An instructional illustration depicting a dosing dial for a pen injector. It shows a hand turning the dial to select insulin units, with examples of 5 units and 24 units selected displayed on a digital dose window. The image demonstrates how to adjust the dose setting on the device.*

FDA Label Image

Hand & Vial Figure (Image 36)

A black and white line drawing showing a hand holding a small vial, illustrating proper handling or holding technique for the vial of Insulin Aspart Protamine and Insulin Aspart Mix 70/30 injection suspension.*

FDA Label Image

Figure A & Figure B (Image 37)

An instructional illustration consisting of two black-and-white line drawings labeled Figure A and Figure B. Both depict a hand holding a vial, showing the process of removing or handling the vial cap for injection preparation.*

FDA Label Image

Figure C (Image 38)

An instructional illustration showing two hands with a double-headed horizontal arrow above, indicating a side-to-side motion or action related to handling or preparing the injection suspension of Insulin Aspart Protamine and Insulin Aspart Mix 70/30.*

FDA Label Image

Figure D (Image 39)

An instructional diagram showing the preparation of an injection using a syringe and vial. The illustration depicts a hand pulling the plunger of a syringe to draw liquid from the vial, with an inset close-up of the syringe filled with liquid.*

FDA Label Image

Figure E (Image 40)

Illustration showing the preparation of an injection using a syringe and vial. One hand holds the vial while the other hand inserts the syringe needle into the vial, depicting the process of drawing medication into the syringe.*

FDA Label Image

Figure F (Image 41)

An instructional illustration showing the preparation of an injection using a syringe. The image depicts a hand holding a vial and another hand drawing liquid into the syringe with an arrow indicating the direction of the plunger movement.*

FDA Label Image

Figure G (Image 42)

An instructional illustration labeled Figure G showing a hand holding a vial upside down while drawing liquid into a syringe held by the other hand, with a downward arrow indicating the motion of drawing. The image likely depicts part of the medication preparation process for subcutaneous injection.*

FDA Label Image

Figure H (Image 43)

An instructional illustration shows hands preparing a syringe and vial, depicting medication withdrawal. One hand holds the vial upside down while the other hand pulls back the syringe plunger to draw medication from the vial, demonstrating preparation for subcutaneous injection of Insulin Aspart Protamine and Insulin Aspart Mix 70/30.*

FDA Label Image

Figure I (Image 44)

An instructional diagram showing a hand holding a vial and a syringe, with an arrow indicating to pull the syringe upward to draw the liquid. An inset shows a close-up view of the syringe filled with the medication. This illustrates the preparation step for subcutaneous injection of Insulin Aspart Protamine and Insulin Aspart Mix 70/30 suspension.*

FDA Label Image

Figure J (Image 45)

An instructional diagram labeled 'Figure J' showing a hand holding a vial and a syringe, with an arrow indicating the action of drawing fluid from the vial using the syringe. This illustrates the preparation step for injection.*

FDA Label Image

Figure L (Image 47)

An instructional illustration depicting a syringe held by two hands, with one hand adjusting a plunger or cap. The image likely shows a step in the preparation or administration process of an injection suspension product.*

FDA Label Image

Figure M (Image 48)

An instructional illustration showing the proper technique for subcutaneous injection. The image depicts one hand pinching the skin on the arm and the other hand holding a syringe poised for injection with an upward arrow indicating the direction to insert or remove the needle.*

FDA Label Image

Pull Off The Pen Cap. (Image 50)

An instructional illustration showing a close-up of a hand holding a syringe, with an arrow indicating the action of pulling back the plunger to withdraw medication. This likely represents a step in preparing an injection.*

FDA Label Image

Roll The Pen Between Your Palms. (Image 51)

An instructional illustration showing a hand holding a vial or syringe with arrows indicating a horizontal shaking or rolling motion. The image appears to demonstrate how to mix or prepare an injection suspension prior to use, likely for subcutaneous administration.*

FDA Label Image

Move The Pen Up And Down. (Image 52)

An instructional illustration showing a sequence of two steps for handling a syringe or injection pen device. The first step depicts a hand holding the device upright, and the second step shows the hand rotating or turning the device downward, indicating a preparation or usage action.*

FDA Label Image

Turn The Dose Selector To 2 Units. (Image 56)

Instructional illustration showing a close-up of a hand adjusting a dose selector on an insulin pen. The display indicates 2 units selected, demonstrating how to set the dose before injection.*

FDA Label Image

Tap The Needle. (Image 57)

Instructional illustration showing a close-up of a finger pressing the plunger of a syringe with liquid inside, with motion lines indicating the injection or mixing action, related to subcutaneous injection preparation or administration for Insulin Aspart Protamine and Insulin Aspart Mix 70/30.*

FDA Label Image

Press The Push-button. (Image 58)

An instructional illustration showing a hand removing the cap from an insulin pen. The image emphasizes lifting the cap straight up and includes a small inset showing the insulin pen with the cap fully removed.*

FDA Label Image

Press The Push Button To Inject. (Image 60)

An instructional illustration showing a hand holding a vial of Insulin Aspart Protamine and Insulin Aspart Mix 70/30, indicating to gently invert or rotate the vial to mix before use. The image emphasizes proper preparation of the injection suspension prior to administration.*

FDA Label Image

Replace The Pen Cap. (Image 62)

An instructional illustration showing a hand manipulating a pen-style injector, likely for medication administration. The image depicts two fingers grasping the pen and an arrow indicating a sliding or twisting motion on the pen barrel or cap.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.